Rylaze (Asparaginase Erwinia Chrysanthemi Drug Interactions
Rylaze (Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rylaze. Always confirm against the full prescribing information.
100 interactions
Abacavir
Asparaginase Escherichia coli may increase the hepatotoxic activities of Abacavir.
Level 2 evidence
Abiraterone
Asparaginase Escherichia coli may increase the hepatotoxic activities of Abiraterone.
Level 2 evidence
Acarbose
Asparaginase Escherichia coli may increase the hepatotoxic activities of Acarbose.
Level 2 evidence
Acetaminophen
Asparaginase Escherichia coli may increase the hepatotoxic activities of Acetaminophen.
Level 2 evidence
Acetazolamide
Asparaginase Escherichia coli may increase the hepatotoxic activities of Acetazolamide.
Level 2 evidence
Acitretin
Asparaginase Escherichia coli may increase the hepatotoxic activities of Acitretin.
Level 2 evidence
Albendazole
Asparaginase Escherichia coli may increase the hepatotoxic activities of Albendazole.
Level 2 evidence
Allantoin
The therapeutic efficacy of Allantoin can be increased when used in combination with Asparaginase Escherichia coli.
Level 2 evidence
Allopurinol
Asparaginase Escherichia coli may increase the hepatotoxic activities of Allopurinol.
Level 2 evidence
Aminosalicylic acid
Asparaginase Escherichia coli may increase the hepatotoxic activities of Aminosalicylic acid.
Level 2 evidence
Amiodarone
Asparaginase Escherichia coli may increase the hepatotoxic activities of Amiodarone.
Level 2 evidence
Anidulafungin
Asparaginase Escherichia coli may increase the hepatotoxic activities of Anidulafungin.
Rylaze (Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn) has 517 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Rylaze (Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn) has 2 major, 180 moderate, and 335 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rylaze. Always confirm against the full prescribing information.